More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

As the global population ages, age-related diseases such as cardiovascular disorders, neurodegeneration, type 2 diabetes, and ...

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Most of us have had a bowl of chicken noodle soup to treat us when we were sick, but what's really going on to help make us ...

Longevity is no longer a male-coded tech endeavor. Here's how women are leading the way at the intersection of technology and ...

Adaptive Biotechnologies’ management is scheduled to participate in a fireside chat on Wednesday, June 11 th at 5:40 a.m. Pacific Time / 8:40 a.m. Eastern Time. Interested parties may access a live ...

A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own "self-care" ...